Protein Tyrosine Kinases
By:Doriano Fabbro,Frank McCormick
Published on 2005-09-01 by Springer Science & Business Media
Leading researchers, from the Novartis group that pioneered Gleevec/GlivecTM and around the world, comprehensively survey the state of the art in the drug discovery processes (bio- and chemoinformatics, structural biology, profiling, generation of resistance, etc.) aimed at generating PTK inhibitors for the treatment of various diseases, including cancer. Highlights include a discussion of the rationale and the progress made towards generating |selective| low molecular-weight kinase inhibitors; an analysis of the normal function, role in disease, and application of platelet-derived growth factor antagonists; and a summary of the factors involved in successful structure-based drug design. Additional chapters address the advantages and disadvantages of in vivo preclinical models for testing protein kinase inhibitors with antitumor activity and the utility of different methods in the drug discovery and development process for determining |on-target| vs |off-target| effects of kinase inhibitors.
This Book was ranked at 15 by Google Books for keyword survival kit for 20 something.
Book ID of Protein Tyrosine Kinases's Books is WJ2KpgGLhIwC, Book which was written byDoriano Fabbro,Frank McCormickhave ETAG "oA27Y29njZ0"
Book which was published by Springer Science & Business Media since 2005-09-01 have ISBNs, ISBN 13 Code is 9781588293848 and ISBN 10 Code is 158829384X
Reading Mode in Text Status is true and Reading Mode in Image Status is true
Book which have "290 Pages" is Printed at BOOK under CategoryMedical
This Book was rated by Raters and have average rate at ""
This eBook Maturity (Adult Book) status is NOT_MATURE
Book was written in en
eBook Version Availability Status at PDF is true and in ePub is true
Book Preview
0 komentar:
Posting Komentar